GT Biopharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US36254L3087
USD
0.54
0.04 (8.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGT Biopharma, Inc. VS Pharmaceuticals & Biotechnology
 
1D
8.54%
-1.23%
1W
-18.36%
-2.45%
1M
-32.13%
-1.5%
YTD
-31.37%
-0.69%
1Y
-75.39%
12.16%
3Y
-41.42%
64.35%
5Y
-99.76%
74.91%
10Y
-99.76%
261.61%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.64%
0%
-2.64%
6 Months
-69.03%
0%
-69.03%
1 Year
-75.39%
0%
-75.39%
2 Years
-88.96%
0%
-88.96%
3 Years
-41.42%
0%
-41.42%
4 Years
-99.32%
0%
-99.32%
5 Years
-99.76%
0%
-99.76%

GT Biopharma, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary